Related Experiment Video
Updated: Aug 7, 2026
07:21
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
Published on: June 16, 2023
Cardiovascular response to treadmill testing in Parkinson disease
William G Werner1, Joanne DiFrancisco-Donoghue, Eric M Lamberg
1Department of Physical Therapy, School of Health Professions, Behavioral and Life Science, New York Institute of Technology, Old Westbury, NY, USA. wwerner@nyit.edu
Journal of Neurologic Physical Therapy : JNPT
|June 27, 2006
Summary
Individuals with Parkinson disease (PD) show normal cardiovascular responses to submaximal exercise. However, half of PD patients exhibit blunted responses at peak exercise intensity, indicating potential exercise prescription needs.
Area of Science:
- Cardiology
- Neurology
- Exercise Physiology
Background:
- Exercise is recommended for maintaining quality of life in Parkinson disease (PD).
- Cardiovascular responses to exercise in PD patients have yielded controversial results.
- Understanding these responses is crucial for safe and effective exercise prescription.
Purpose of the Study:
- To compare vital signs and Rate of Perceived Exertion (RPE) during treadmill exercise between individuals with PD and healthy controls.
- To identify potential differences in cardiovascular response at submaximal and peak exercise intensities.
Main Methods:
- Twenty-seven volunteers (16 with PD, 11 healthy) underwent a Modified Bruce Protocol treadmill test.
- Heart rate (HR), systolic blood pressure (BP), and RPE were measured.
- PD subjects were grouped by their ability to reach target heart rate.
Main Results:
- No significant differences in HR, BP, or RPE were observed between groups at submaximal exercise.
- At peak exercise, approximately 50% of PD subjects displayed blunted cardiovascular responses.
- These blunted responses occurred despite achieving comparable exercise intensity.
Conclusions:
- Cardiovascular responses to lower-intensity exercise appear similar in PD patients and healthy individuals.
- Higher exercise intensities reveal abnormal cardiovascular responses in a significant portion of PD patients.
- Exercise stress testing is recommended to guide personalized exercise prescription for individuals with PD.
Related Concept Videos
01:26Exercise Stress Test
Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...